Neurotech Podcast

Neurotech Podcast


023 – Jeff June

August 27, 2019

Jeff June is the founder and CEO of IschemiaCare. Jeff comes from a background in venture capital and private equity, and held the Forsythe Chair in Entrepreneurship at Miami University of Ohio.
Top 3 Takeaways

In 40% of stroke cases, the specific cause is unknown.
* Stroke care can benefit from greater diagnostic personalization.
* Having the right people in your life and on your team is an outsized advantage.

Show Notes

* [1:00] Jeff’s background.
* [2:45] Origin of IschemiaCare.
* [5:52] What IschemiaCare does.
* [8:05] A-fib stroke.
* [10:20] How IschemiaCare gains usage.
* [13:30] IschemiaCare’s business model.
* [15:20] Growth plan.
* [16:00] IschemiaCare’s product and how it fits into stroke care pipeline.
* [17:50] The RNA data play.
* [19:40] Extrapolating data insights.
* [23:40] Key lessons about healthtech.
* [27:30] Reminding people of your mission.
* [30:00] Doug’s meme on the Loup website.

Selected Links

* IschemiaCare
* Stroke care guidelines

Related Podcasts

* 020 – Mary Beth Henderson
* 017 – Ana Maiques
* 013 – Ladan Jiracek, Manfred Franke, and Doug Clinton

Disclaimer